


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-14.44%
+22.49%
+0.48%
+12.65%
+2.37%
CC
Chemours Company
$12.70
Strengths

Upgraded on attractively valued

Trading below its fair value

Outperform the market
CC Price Performance
$12.75 (-0.39%)
$16.75 (-24.18%)
$13.67 (-7.10%)
$17.47 (-27.30%)
CC has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

CC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Reported a weak earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Trading below its fair value

Outperform the market
![]()
CC Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CC Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is CC current stock price?
What are CC stock strengths?
What is CC Risk Level?
What is CC market cap and volume?
What is CC current Stock IQ?
Should I buy CC stock right now?
Is CC a Strong Buy right now?
What does a 'Strong Buy' rating mean for CC?
What does a 'Strong Sell' rating mean for CC?
What factors influence CC's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-14.44%
+22.49%
+0.48%
+12.65%
+2.37%
CC
Chemours Company
Current Price
$12.70
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value

Outperform the market

CC Price Performance
$12.75 (-0.39%)
$16.75 (-24.18%)
$13.67 (-7.10%)
$17.47 (-27.30%)
CC Analysts Opinion
CC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Reported a weak earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Trading below its fair value

Outperform the market
![]()
CC Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
CC Street Sentiment is extremely bullish and have positive views on the near-term outlook
CC has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
CC Stock IQ
CC Latest Analysis
ish Two Hundred Day Moving Average Cross - CC. In trading on Friday shares of Chemours Co (Symbol: CC) crossed above their 200 day moving average of $13.19 changing hands as high as $13.32 per share. Chemours Co shares are currently trading up about 5.6% on the day. The chart below shows the one year performance of CC sh
Fri Dec 5, 2025
JP Morgan Maintains Chemours (CC) Neutral Recommendation. Fintel reports that on December 3 2025 JP Morgan maintained coverage of Chemours (NYSE:CC) with a Neutral recommendation. Analyst Price Forecast Suggests 28.80% Upside
Thu Dec 4, 2025
Chemours (CC) PT Cut to $17 by RBC Capital Following Q3 Miss Cites TiO2 Pricing Pressure. The Chemours Company (NYSE:CC) is one of the cheap US stocks to buy according to analysts. On November 10 RBC Capital analyst Arun Viswanathan lowered the firms price target on Chemours to $17 from $19 and kept an Outperform rating on the shares after the company saw Q3 2025 earnings miss. Viswanathan noted that the [….]
Fri Nov 21, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.